Best hope or last hope: access to phase III clinical trials of HER-2/neu for advanced stage breast cancer patients. [electronic resource]
Producer: 20000315Description: 259-66 p. digitalISSN:- 0309-2402
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase III as Topic -- nursing
- Female
- Health Services Accessibility -- standards
- Humans
- Neoplasm Staging
- Patient Selection
- Proto-Oncogene Mas
- Proto-Oncogene Proteins -- immunology
- Receptor, ErbB-2 -- immunology
- Research Subjects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.